To further confirm if CCR6 upregulation is involved in the development of SSc vasculopathy, we evaluated the effect of Ccr6 siRNA on the vascular aspect of BLM-treated mice, a widely recognized animal model of SSc. Here, CCR6 is linked to systemic sclerosis.